Craig-Hallum analyst Chase Knickerbocker lowered the firm’s price target on Indivior (INDV) to $15 from $16 and keeps a Buy rating on the shares. The firm says the company’s solid beat was overshadowed by a “disappointing” 2025 outlook driven by Suboxone erosion.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on INDV: